The erythrocyte skeleton plays an essential role in determining the shape and deformability of the red cell. Disruption of the interaction between components of the red cell membrane skeleton may cause loss of structural and functional integrity of the membrane. Several observations based on studies in vitro strongly suggest that phosphorylation may modify interactions between proteins, leading to a reduced affinity. In particular, increased phosphorylation of ␤-spectrin decreases membrane mechanical stability. In order to investigate the presence of membrane protein defects we investigated the erythrocyte membrane protein composition and phosphorylation in 22 children with leukemia at diagnosis and during the remission phase. Sixteen children had acute lymphoblastic leukemia (ALL), three had chronic myeloid leukemia (CML) and three had acute myeloid leukemia (AML). Ten patients (eight ALL and two CML) displayed elliptocytosis and poikilocytosis, an increase of spectrin dimers (41.8 ± 15.6) and an enhanced phosphorylation of ␤-spectrin (108 ± 15%) at diagnosis. These alterations disappeared during the remission phase. This is the first demonstration of a reversible erythrocyte membrane alteration in leukemia. Since the ␤-spectrin phosphate sites are located near the C-terminal region and close to the head of the ␤-chain that is involved in dimer-dimer interaction, we supposed that the ␤-chain phosphorylation has an effect upon the interactions between spectrin dimers, ie the tetramerization process. The weakening of this process should be responsible for the presence of elliptocytes and poikilocytes as reported in hereditary elliptocytosis and pyropoikilocytosis. Leukemia (2001) 15, 440-444.
Introduction
The red blood cell membrane is one of the major determinants of the ability of erythrocytes to cross repeatedly through the microcirculation. 1 The skeleton that laminates the inner side of the red cell membrane plays an essential role in determining the shape and deformability of the red cell. 1 Defects and deficiencies in the erythrocyte membrane protein structure have been described in several hereditary and acquired anaemias, where they give rise to mechanically and/or thermally unstable erythrocytes with shortened life spans. [2] [3] [4] Spectrin, the most abundant skeletal protein, consists of two chains, ␣ and ␤, intertwined in an antiparallel manner to form dimers. 5 Self-association of spectrin dimers into tetramers is perhaps the best-characterised interaction of membrane proteins, allowing the erythrocyte to acquire its mechanical properties. 6 Disruption of spectrin self-association has been shown to lead to hereditary elliptocytosis and pyropoikilocytosis. 2, 3, 6, 7 Defects of the COOH-terminal end of the ␤-chain, ie the 'head' of the molecule, may lead to impaired spectrin selfassociation. 6 ␤-spectrin consists of 17 homologous 106-amino acid repeat segments and a short nonhomologous COOH-terminal segment that contains a consensus sequence for at least four casein kinase I phosphorylation sites. 8 Evidence shows that the shape and the deformability of the red blood cell membrane are very sensitive to the state of phosphorylation. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] In particular, increased phosphorylation of ␤-spectrin decreases membrane mechanical stability. 19 Several acquired abnormalities of erythrocytes and platelets have been described in leukemia and myelodysplastic syndromes. Some examples of these abnormalities are acquired thalassaemia, 20, 21 abnormal piruvate kinase, 22 size and shape changes of erythrocytes, [23] [24] [25] erythrocyte membrane defects, [26] [27] [28] [29] [30] [31] [32] [33] platelet defects of von Willebrand factor 34 and of membrane glycoproteins. 35 Here, we further investigated the erythrocyte membrane abnormalities in childhood leukemias. Our studies demonstrate that an erythrocyte skeletal destabilization is due to an increase of the ␤-spectrin phosphorylation and that it disappears during the remission phase.
Materials and methods

Subjects
All blood samples were obtained from 22 patients (age 9.5 ± 2.7 years) and healthy volunteers after informed consent. Sixteen children had acute lymphoblastic leukemia (ALL), three had chronic myeloid leukemia (CML) and three had acute myeloid leukemia (AML) ( Table 1) . None of the patients had been on any pharmacological treatment for at least 4 weeks prior to the study. Haemoglobin level, reticulocyte count, peripheral blood smear and RBC osmotic fragility was evaluated at diagnosis and during the remission phase.
Erythrocyte membrane protein analysis
The methods used to analyze the erythrocyte membrane proteins have previously been described 36, 37 and included: (1) erythrocyte membrane preparation; (2) analysis of the red cell membrane proteins by sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) (3.5-17% exponential gradient Fairbanks gels and 4-12% linear Laemmli gels); (3) spectrin extraction at 4°C and relative determination of spectrin dimers and spectrin tetramers by non-denaturing gel electrophoresis (PAGE) at 4°C; and (4) limited tryptic digestion of spectrin. Biochemical analysis was performed at diagnosis and during the remission phase.
Phosphorylation of intact cells
Red cells from controls and patients were washed in the incubation buffer: sodium chloride, 120 mm; sodium bicarbonate, 441 Table 1 Haematological and biochemical data of leukemic children at diagnosis. 20 mm; potassium chloride, 5 mm; magnesium chloride, 1 mm; dextrose, 10 mm; bovine serum albumin, 1 mg/ml; and penicillin and streptomycin (100 g/ml each). Red cells were suspended in the incubation mixture to a 10% hematocrit and 0.2 mCi of carrier-free 32 PO 4 was added for each milliliter of packed erythrocytes. The samples were incubated for 32 h with gentle agitation at 37°C in 5% CO 2 atmosphere. 38 Erythrocyte ghosts were prepared as described above and radiolabeled proteins were resolved by SDS-PAGE according to Fairbanks et al, 39 a method in which ␤-spectrin is well separated from ankyrin. Protein concentrations were determined by the method of Lowry et al 40 and equal amounts of proteins were loaded on gel. The gel was stained with Coomassie Brillant Blue and dried. Phosphorylated membrane proteins were identified by autoradiography and the reactive proteins were quantitated by laser-densitometric scanning compared to control (Ultroscan; LKB, Sweden). Phosphorylation analysis of each patient was performed three times using different gels with a reproducibility within a range of ±8%.
Phosphorylation studies were repeated during the remission phase.
Results
All patients had anemia (hemoglobin: 8.7 ± 0.8 g/l) with low reticulocyte counts (34.4 ± 9.0 × 10 9 /l) and normal osmotic fragility at diagnosis (Table 1) . Peripheral blood smears showed elliptocytosis and poikilocytosis in 10 patients (eight ALL and two CML) ( Figure 1 and Table 1 ). One-dimensional SDS-PAGE analysis of erythrocyte membrane proteins from patients was qualitatively and quantitatively normal, compared with control subjects (data not shown). PAGE of spectrin
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Figure 1
Peripheral blood smear of patient 8. The patient has elliptocytes and poikilocytes at diagnosis (a) and normal red blood cells during the remission phase (b).
Figure 2
Non-denaturing gel electrophoresis of patient 8. The patient has an increased spectrin dimer percentage at diagnosis (a) and normalizes during the remission phase (b). C, control; D, spectrin dimers, T, spectrin tetramers. extracts performed at 4°C showed an increase in the percentage of spectrin dimers out of the total pool of spectrin, ie spectrin dimers and tetramers, averaging 41.8 ± 15.6 (normal being Ͻ10%) in 10 patients (eight ALL and two CML) at diagnosis (Table 1 and Figure 2 ). The increase of spectrin dimers seems to correlate with the presence of elliptocytes (Table 1) . Phosphorylation studies of the major membrane proteins showed an enhanced phosphorylation of ␤-spectrin (mean increase: 108 ± 15%, compared with control erythrocytes) in patients with high spectrin dimers (Figure 3) . A significant association between spectrin dimer percentage and ␤-spectrin phosphorylation was found (P Ͻ 0.0005). The average phosphorylation of the other proteins, eg band 3 and protein 4.9, did not show significant differences. Peripheral blood smears, percentage of spectrin dimers and ␤-spectrin phosphorylation normalized during the remission phase (Figures 1, 2 and 3 ) except in one subject with CML. To rule out a genetically determined spectrin abnormality in this patient, eg hereditary elliptocytosis, we performed a limited tryptic digestion of
Figure 3
Autoradiograms of phosphorylated erythrocyte proteins of patient 8. Coomassie Blue-stained (CB) gel is included for comparison of the stained and labelled bands. The arrow shows the ␤-spectrin phosphorylation. C, control. (a) at diagnosis; (b) during the remission phase. spectrin followed by monodimensional fractionation using SDS-PAGE that revealed a normal pattern (data not shown). Moreover, the patient's parents showed no unusual erythrocyte morphology on blood smear.
Discussion
Manno et al 19 demonstrated that the phosphorylation of ␤-spectrin can modulate the physiological function of native erythrocyte membrane and that the increased or decreased phosphorylation of ␤-spectrin decreases or increases membrane mechanical stability, respectively. Several observations based on studies in vitro strongly suggest that phosphorylation may modify interactions between proteins, leading in all cases to a reduced affinity.
9-18 Our study shows an ellipto-poikilocytosis, an abnormal spectrin dimer percentage and an increased ␤-spectrin phosphorylation in 10 patients with leukemia at diagnosis with their normalization during the remission phase. Although in vitro studies showed that the phosphorylation did not affect the dimer-tetramer equilibrium of spectrin 41, 42 and the erythrocyte shape, 43 our results show a different pattern in vivo. Since the ␤-spectrin phosphate sites are located near the C-terminal region and close to the head of the ␤-chain that is involved in dimer-dimer interaction, we suppose that the phosphorylation of the ␤-chain has an effect upon the interactions between spectrin dimers, ie the tetramerization process. Indeed, we found a significant association between spectrin dimer percentage and ␤-spectrin phosphorylation (P Ͻ 0.0005). The weakening of the tetramerization process should be responsible for the presence of elliptocytes and poikilocytes as reported in hereditary elliptocytosis and pyropoikilocytosis. 2, 3, 6, 7 Abnormalities in the erythrocyte membrane structure in leukemia have been previously reported. [26] [27] [28] [29] [30] Basu et al 27 and Kundu et al [28] [29] [30] showed increased spectrin dimers, abnormal thermal sensity, reduction of ankyrin-binding sites of band 3 and enhanced phosphorylation of membrane protein 4.1 in leukemic erythrocytes. However, these results seem to be in contrast. In fact, the reduction of ankyrin-band 3 connection and the phosphorylation of protein 4.1 with reduced binding to spectrin lead to spherocytosis with increased osmotic fragility. [2] [3] [4] 44 In contrast, the increase of spectrin dimers and the abnormal erythrocyte thermal sensity lead to elliptocytosis. 2, 3, 6, 7 In our study, the erythrocyte morphology, ie elliptocytes, the biochemical pattern, ie spectrin dimers, and the phosphorylation of a membrane protein, ie ␤-spectrin, are in agreement as demonstrated by their normalization during the remission phase. This is the first example of a reversible erythrocyte membrane alteration in leukemia. The CML patient who still showed a high dimer percentage after the first cycle of therapy although reduced (47% vs 29%), had no remission.
These abnormalities also suggest that the defective erythrocytes could be precociously destroyed by the spleen, making these patients more severely anaemic. We found no correlation between dimer percentage and hemoglobin level or reticulocyte value (P Ͼ 0.05 and P Ͼ 0.1, respectively), but this is probably due to the small number of patients.
The reasons why only some patients with leukemia have the erythrocyte abnormalities and the origin of this increased phosphorylation are unknown. The causes are probably multiple and may include stress erythropoiesis and perhaps humoral factors derived by the leukemic cells. Spectrin phosphorylation depends on the ATP level 19, 45 and oncogenes might have some regulatory role for the expression of membrane casein kinase. A reversible effect of erythrocyte skeleton destabilization has been observed, further studies need to establish the nature of this alteration and if the patients with abnormal membrane proteins have a different course of the illness, eg a more severe anemia.
